Grown Rogue International (GRUSF) Amortization of Deferred Charges (2018 - 2021)
Grown Rogue International's (GRUSF) quarterly Amortization of Deferred Charges came in at $48605.0 in Q1 2021, up 35.68% year-on-year from $35822.0 in Q1 2020, and up 82.09% quarter-over-quarter from $26693.0 in Q4 2020.
Grown Rogue International (GRUSF) Amortization of Deferred Charges (2018 - 2021) Analysis & Trends
Grown Rogue International's Amortization of Deferred Charges history runs 4 years deep, the most recent figure standing at $48605.0 for Q1 2021.
- On a quarterly basis, Amortization of Deferred Charges rose 35.68% year-over-year to $48605.0 in Q1 2021; TTM through Jan 2021 was $46708.0, a N/A change from a year earlier, with the FY2020 full-year figure at $96845.0, changed N/A from the prior year.
- Amortization of Deferred Charges improved to $48605.0 in Q1 2021 per GRUSF's latest filing, from $26693.0 in the prior quarter.
- Across five years, Amortization of Deferred Charges topped out at $48605.0 in Q1 2021 and bottomed at -$49687.0 in Q3 2020.
- The 4-year median for Amortization of Deferred Charges is $21097.0 (2020), against an average of $7322.1.
- Across the five-year window, Amortization of Deferred Charges jumped 130.62% in 2019 and slumped 460.05% in 2020, its largest moves.
- Year by year, Amortization of Deferred Charges stood at -$45075.0 in 2018, then surged by 130.62% to $13800.0 in 2019, then jumped by 93.43% to $26693.0 in 2020, then jumped by 82.09% to $48605.0 in 2021.
- Per Business Quant, the three latest GRUSF Amortization of Deferred Charges figures stand at $48605.0 (Q1 2021), $26693.0 (Q4 2020), and -$49687.0 (Q3 2020).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Grown Rogue International | 99.97 Mn | 92.67 Mn | 3.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2021 | 48,605.00 |
| Jan 31, 2021 | 48,605.00 |
| Oct 31, 2020 | 26,693.00 |
| Oct 31, 2020 | 26,693.00 |
| Jul 31, 2020 | -49,687.00 |
| Jul 31, 2020 | -49,687.00 |
| Apr 30, 2020 | 21,097.00 |
| Apr 30, 2020 | 21,097.00 |
| Jan 31, 2020 | 35,822.00 |
| Jan 31, 2020 | 35,822.00 |
| Jul 31, 2019 | 13,800.00 |
| Jul 31, 2019 | 13,800.00 |
| Jul 31, 2018 | -45,075.00 |
| Jul 31, 2018 | -45,075.00 |